Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
124.6 EUR | +0.65% | +2.76% | +57.86% |
Apr. 11 | Berenberg Reiterates UCB's Purchase Rating, Raises PT | MT |
Apr. 11 | UCB : Berenberg, Buy, raises its price target | CF |
Sales 2024 * | 5.62B 6B | Sales 2025 * | 6.31B 6.75B | Capitalization | 23.63B 25.27B |
---|---|---|---|---|---|
Net income 2024 * | 466M 498M | Net income 2025 * | 880M 941M | EV / Sales 2024 * | 4.5 x |
Net Debt 2024 * | 1.63B 1.74B | Net Debt 2025 * | 802M 857M | EV / Sales 2025 * | 3.87 x |
P/E ratio 2024 * |
50.8
x | P/E ratio 2025 * |
25.8
x | Employees | 8,767 |
Yield 2024 * |
1.12% | Yield 2025 * |
1.17% | Free-Float | 61.44% |
Latest transcript on UCB
1 day | +0.65% | ||
1 week | +2.76% | ||
Current month | +8.87% | ||
1 month | +8.78% | ||
3 months | +42.67% | ||
6 months | +77.93% | ||
Current year | +57.86% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 65 | 11-05-31 | |
Sandrine Dufour
DFI | Director of Finance/CFO | 57 | 20-06-30 |
Chief Tech/Sci/R&D Officer | 63 | 17-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 66 | 16-04-27 | |
Dame Davies
BRD | Director/Board Member | 73 | 13-12-31 |
Chief Executive Officer | 65 | 11-05-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.88% | 2 M€ | +7.72% | ||
0.72% | 14 M€ | +5.66% | - | |
0.72% | 5 M€ | +10.09% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 124.6 | -0.44% | 371,409 |
24-04-25 | 125.1 | +3.56% | 349,967 |
24-04-24 | 120.8 | -0.78% | 179,471 |
24-04-23 | 121.8 | -0.20% | 184,505 |
24-04-22 | 122 | +0.66% | 311,888 |
Real-time Euronext Bruxelles, April 26, 2024 at 11:35 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+57.86% | 25.43B | |
-4.66% | 87.53B | |
+1.32% | 40.42B | |
-19.27% | 29.48B | |
-17.69% | 11.49B | |
-43.00% | 11.3B | |
-9.14% | 11.1B | |
+5.24% | 8.75B | |
-8.42% | 7.99B | |
+2.29% | 7.67B |
- Stock Market
- Equities
- UCB Stock